BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 23626825)

  • 1. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
    Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
    PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
    Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Schwarz CG; Reid R; Baker MC; Perkerson RB; Lowe VJ; Rademakers R; Jack CR; Josephs KA
    Brain Lang; 2015 Mar; 142():45-53. PubMed ID: 25658633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
    Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
    J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia.
    Rohrer JD; Caso F; Mahoney C; Henry M; Rosen HJ; Rabinovici G; Rossor MN; Miller B; Warren JD; Fox NC; Ridgway GR; Gorno-Tempini ML
    Brain Lang; 2013 Nov; 127(2):121-6. PubMed ID: 23395096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
    J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
    J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
    Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
    Sintini I; Schwarz CG; Martin PR; Graff-Radford J; Machulda MM; Senjem ML; Reid RI; Spychalla AJ; Drubach DA; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2019 Apr; 40(5):1618-1631. PubMed ID: 30549156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Josephs KA; Martin PR; Botha H; Schwarz CG; Duffy JR; Clark HM; Machulda MM; Graff-Radford J; Weigand SD; Senjem ML; Utianski RL; Drubach DA; Boeve BF; Jones DT; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Whitwell JL
    Ann Neurol; 2018 Mar; 83(3):599-611. PubMed ID: 29451323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
    Whitwell JL; Lowe VJ; Duffy JR; Strand EA; Machulda MM; Kantarci K; Wille SM; Senjem ML; Murphy MC; Gunter JL; Jack CR; Josephs KA
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1357-64. PubMed ID: 23946416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-phase
    Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
    Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation.
    Teichmann M; Kas A; Boutet C; Ferrieux S; Nogues M; Samri D; Rogan C; Dormont D; Dubois B; Migliaccio R
    Brain; 2013 Nov; 136(Pt 11):3474-88. PubMed ID: 24108322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive transcortical sensory aphasia and progressive ideational apraxia owing to temporoparietal cortical atrophy.
    Funayama M; Nakajima A
    BMC Neurol; 2015 Nov; 15():231. PubMed ID: 26559349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.
    Tetzloff KA; Duffy JR; Clark HM; Strand EA; Machulda MM; Schwarz CG; Senjem ML; Reid RI; Spychalla AJ; Tosakulwong N; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Brain; 2018 Jan; 141(1):302-317. PubMed ID: 29228180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary progressive aphasia and Alzheimer's disease: brief history, recent evidence.
    Kirshner HS
    Curr Neurol Neurosci Rep; 2012 Dec; 12(6):709-14. PubMed ID: 22932755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.